. 1/2018. 2. Approved the appropriation and retaining of the net profit Baht 511 million as legal reserve and the declaration of dividend payment from the Company consolidated net profit for the period
VGI Malaysia 25% 75% 25% 51% (2) 74.8% 83.9% 90% 49% 100% 90% 25% 25.1% 10% (1) VGI holds 11% of TCSB for and on behalf of VGM under the Declaration of Trust (2) PBSB holds 11% of TCSB for and on behalf
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator
transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
Sales 9,643.6 10,351.4 9,933.1 Gross margin, (%) 20.3% 26.0% 30.0% Selling &Administration 1,612.8 1,804.3 1,817.6 Net Profit 934.5 2,014.9 -53.6% 2,544.5 -20.8% 7.7% 14.4% 17.9% The year 2019 continued
administration. On 10 January 2020, the Company acquired Metropolis Office Building with Net Leasable Area approximately 26,157 square meters, including related movable assets that are necessary to operate
Administration Agreement” และจ่ายคา่ธรรมเนียมให้กบับริษัท อิออน ไฟแนนเชียล เซอร์วิส จํากดั (“AFS”) เป็นจํานวน 108,824,834 บาท โดยคิดเป็นร้อยละ 0.89 ของ สนิทรัพย์ทีมีตวัตนสทุธิและมีมตอินมุตัิจา่ยคา่ธรรมเนียมใบ